Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Regis Healthcare.
RELATED STOCKHEAD STORIES
Health & Biotech
‘Once in a generation opportunity’ to transform healthcare via digital innovation
Health & Biotech
CRITERION: Are profits on the horizon for the ASX’s aged care orphan?
News
ASX Rebalance: Tech in, lithium out of S&P/ASX 200 as uranium stocks enter S&P/ASX 300
Experts
MoneyTalks: Jarden bullish on Regis Healthcare; gives price targets on these 4 ASX online classified stocks
Experts
CRITERION: Three small caps that tick three boxes for a boom ’24
Health & Biotech
ScoPo’s Powerplays: ASX healthcare 0.3% up as focus shifts to M&A activity in 2024
Health & Biotech
ASX Health Stocks: EBR stumbles 11pc after warning of FDA delay; Firebrick’s trial data shows ‘inaccuracies’
News
ASX Small Cap Lunch Wrap: ASX makes it five wins in a row, hoists lunch flag back above 7,000 points
News
MoneyTalks: Marc says arm yourself with these cash-rich, divvy-paying ASX small caps for the new economic stand-off
News
Rise and Shine: Everything you need to know before the ASX opens
Experts
CRITERION: Have you put your post-Budget bets on yet?
News
CRITERION: Investing in aged care – it never gets old
Health & Biotech
ASX Health Stocks: GTG set to jump into online after buying ecommerce outfit AffinityDNA
Experts
ScoPo’s Powerplays: Health stocks bounce up and down as markets tumble
Health & Biotech
ASX Health Stocks: EU approval set to open up Wellfully’s knee patch to European markets
Experts
ScoPo’s Powerplays: Which ASX health stocks are winners from the Federal Budget?
Health & Biotech
